Cycloplegia in African-American children.

Area of Science:

• Ophthalmology
• Pediatric Eye Care
• Pharmacology

Background:

• Cycloplegic agents are crucial for accurate refractive error assessment and ocular biometry.
• Tropicamide is commonly used but may be less effective in individuals with darker irides iris pigmentation.
• The Orinda Longitudinal Study of Myopia (OLSM) utilized tropicamide for Caucasian children.

Purpose of the Study:

• To evaluate the efficacy of a combined tropicamide and cyclopentolate regimen for cycloplegia and mydriasis in African-American children.
• To determine if this combination provides adequate conditions for cycloplegic refraction and ocular component measurements.
• To address the potential limitations of tropicamide monotherapy in darker-pigmented irises.

Main Methods:

• Nineteen African-American children (ages 5.5-15.6 years) participated.
• Accommodative responses were measured using an autorefractor before and after instillation of tropicamide and cyclopentolate.
• A Badal lens system was used to provide controlled accommodative stimuli (1.00 D, 2.00 D, 4.00 D).

Main Results:

• Pupil dilation was rapid and maximal (7.3 mm) by 30 minutes post-instillation.
• Accommodative responses were significantly reduced after the combined drops, indicating effective cycloplegia.
• Reduced accommodative responses were observed across all stimulus levels at 30, 45, and 60 minutes.

Conclusions:

• The combination of 1% tropicamide and 1% cyclopentolate is highly effective for achieving adequate cycloplegia and mydriasis in African-American children.
• This regimen facilitates accurate ocular biometry and cycloplegic refractions in this population.
• The findings support the use of this combined approach for pediatric eye examinations in African-American children.